|
1
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Loree JM and Cheung WY: Optimizing
adjuvant therapy and survivorship care of stage III colon cancer.
Future Oncol. 12:2021–2035. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rogowski W and Sulżyc-Bielicka V: Optimal
duration of a first-line palliative chemotherapy in disseminated
colorectal cancer-a review of the literature from a developing
country perspective. Contemp Oncol (Pozn). 20:210–214.
2016.PubMed/NCBI
|
|
4
|
Hu T, Li Z, Gao CY and Cho CH: Mechanisms
of drug resistance in colon cancer and its therapeutic strategies.
World J Gastroenterol. 22:6876–6889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan S, Shi H, Ba M, Lin S, Tang H, Zeng X
and Zhang X: miR-409-3p sensitizes colon cancer cells to
oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Mol
Med. 37:1030–1038. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scott KL, Kabbarah O, Liang MC, Ivanova E,
Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, et al:
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in
cancer. Nature. 459:1085–1090. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scott KL and Chin L: Signaling from the
Golgi: Mechanisms and models for Golgi phosphoprotein 3-mediated
oncogenesis. Clin Cancer Res. 16:2229–2234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu
R, Chen K, Li J and Song L: Overexpression of GOLPH3 promotes
proliferation and tumorigenicity in breast cancer via suppression
of the FOXO1 transcription factor. Clin Cancer Res. 18:4059–4069.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kunigou O, Nagao H, Kawabata N, Ishidou Y,
Nagano S, Maeda S, Komiya S and Setoguchi T: Role of Golph3 and
Golph3L in the proliferation of human rhabdomyosarcoma. Oncol Rep.
26:1337–1342. 2011.PubMed/NCBI
|
|
10
|
Qiu CZ, Yu WS and Wang CX: Expression and
clinical significance of Golgi phosphorylation protein 3 in
colorectal cancer tissues. Chin J Exp Surg. 30:461–463. 2013.(In
Chinese).
|
|
11
|
Yu WS, Qiu CZ and Wang CX: Golph3
expression and apoptosis in colorectal cancer cells. Clin Oncol.
40:1094–1463. 2013.(In Chinese).
|
|
12
|
Yang XF, Qiu CZ and Wang CX: Relationship
between golgi phosphorylation protein 3 expression and prognosis in
colorectal cancer. Chin J General Surg. 23:1362–1366. 2014.(In
Chinese).
|
|
13
|
Guo YT, Qiu CZ, Huang ZX, Yu WS, Yang XF
and Wang MZ: Correlational research of Golgi phosphorylation
protein 3 expression in colorectal cancer. World J Gastroenterol.
21:13473–13479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu CZ, Wang MZ, Yu WS, Guo YT, Wang CX
and Yang XF: Correlation of GOLPH3 gene with wnt signaling pathway
in human colon cancer cells. J Cancer. 7:928–934. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ah KK, Young KJ, Ah LY, Min A, Yil BY and
Heon SM: Entamoeba histolytica induces cell death of HT29 colonic
epithelial cells via NOX1-Derived ROS. Korean J Parasitol.
51:61–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wigmore PM, Mustafa S, El-Beltagy M, Lyons
L, Umka J and Bennett G: Effects of 5-fu. Adv Exp Med Biol.
678:157–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang N, Yin Y, Xu SJ and Chen WS:
5-fluorouracil: Mechanisms of resistance and reversal strategies.
Molecules. 13:1551–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Shi H, Tang H, Fang Z, Wang J and
Cui S: miR-218 inhibits the invasion and migration of colon cancer
cells by targeting the PI3K/Akt/mTOR signaling pathway. Int J Mol
Med. 35:1301–1308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Moerkens M, Ramaiahgari S, de
Bont H, Price L, Meerman J and van de Water B: Elevated
insulin-like growth factor 1 receptor signaling induces
antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling
routes. Breast Cancer Res. 13:R522011. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Zhang X, Wu X, Li W, Su P, Cheng
H, Xiang L, Gao P and Zhou G: linterference of frizzled 1 (FZD1)
reverses multidrug resistance in breast cancer cells through the
Wnt/β-catenin pathway. Cancer Lett. 323:106–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeon SH, Yoon JY, Park YN, Jeong WJ, Kim
S, Jho EH, Surh YJ and Choi KY: Axin inhibits extracellular
signal-regulated kinase pathway by ras degradation via
beta-catenin. J Biol Chem. 28:14482–14492. 2007. View Article : Google Scholar
|
|
23
|
Jin C, Samuelson L, Cui CB, Sun Y and
Gerber DA: MAPK/ERK and Wnt/β-Catenin pathways are synergistically
involved in proliferation of Sca-1 positive hepatic progenitor
cells. Biochem Biophys Res Commun. 409:803–807. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim D, Rath O, Kolch W and Cho KH: A
hidden oncogenic positive feedback loop caused by crosstalk between
Wnt and ERK pathways. Oncogene. 26:4571–4579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matuo R, Sousa FG, Escargueil AE,
Grivicich I, Garcia-Santos D, Chies JA, Saffi J, Larsen AK and
Henriques JA: 5-Fluorouracil and its active metabolite FdUMP cause
Dna damage in human SW620 colon adenocarcinoma cell line. J Appl
Toxicol. 29:308–316. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Farber-Katz SE, Dippold HC, Buschman MD,
Peterman MC, Xing M, Noakes CJ, Tat J, Ng MM, Rahajeng J, Cowan DM,
et al: DNA damage triggers Golgi dispersal via DNA-PK and GOLPH3.
Cell. 156:413–427. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buschman MD, Rahajeng J and Field SJ:
GOLPH3 links the Golgi, DNA damage, and cancer. Cancer Res.
75:624–627. 2015. View Article : Google Scholar : PubMed/NCBI
|
